Also listed on Janssen Biologics B.V., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Nov 15, 2042 · High confidence
20-year base term ends Jul 8, 2042
Filed Jul 8, 2022 as application 17/860,416 · Granted Jan 27, 2026
Base term plus 130 days of patent term adjustment (USPTO delay)
Today
2022
2042
Clock starts
Jul 8, 2022
Jul 8, 2022
Term ends
Nov 15, 2042
Nov 15, 2042
Granted
Jan 27, 2026
Jan 27, 2026
base term
patent term adjustment
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
130
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 130 days past its 20-year base term on prosecution delay. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jul 8, 2022, when this application, 17/860,416, was filed | Jul 8, 2042 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +130 days, USPTO patent term adjustment record | Nov 15, 2042 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Nov 15, 2042 | High confidence |
This family
| US 12,534,524 | this patent Nov 2042 | Nov 2042 |
| Application 19/426,887 | Pending not computed | not computed |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Apr 20, 2026 Reel 74415, frame 493 | Hayes, Ronan; Twomey, Denis; Johnston, Robin; Gordon, Gary; Donlon, Ann | Janssen Sciences Ireland Unlimited Company | Assignment of Assignor's Interest |
| Apr 20, 2026 Reel 74415, frame 594 | Steenvoorden, Willem | Janssen Biologics B.V. | Assignment of Assignor's Interest |
| Apr 20, 2026 Reel 74415, frame 788 | Goochee, Charles | Centocor Research & Development, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Nov 2042
Term ends Nov 15, 2042. Maintenance fees still fall due before then
Note
The 130 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
We have no citation count for this patent yet. That is not the same as never having been cited.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.